G20 F06.7
Conditions
Interventions
Group 1: Participants with idiopathic Parkinson’s disease and mild cognitive impairment receive app-based cognitive training using NeuroNation MED for 12 weeks. Training is performed three times per w
Sponsors
Asklepios Fachklinikum
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of idiopathic Parkinson’s disease (ICD-10: G20) Mild cognitive impairment (MCI/F06.7) Mild impairment in at least one CERAD subdomain Capacity to provide informed consent Ability to use a mobile device Availability of a mobile device Ability to understand German-language instructions
Exclusion criteria
Exclusion criteria: Moderate or severe dementia Severe cognitive impairment (CERAD z < -1.64) Legal guardianship Paresis of the dominant hand or arm Relevant visual field deficits Severe non-correctable visual impairment Severe aphasia Use of other cognitive training programs or training applications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in general cognitive performance after 12 weeks of intervention measured by the Neuropsychological Assessment Battery (NAB). Time points: Baseline (T1); After 12 weeks (T2) Assessment method: Standardized neuropsychological assessment using the NAB. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in psychological well-being, self-efficacy, depressive symptoms, subjective cognitive functioning, health-related quality of life, health literacy, and usability after 12 weeks. Assessment instruments: Health-49 HADS-D FLei PDQ-39 HLQ-G System Usability Scale (SUS) Time points: Baseline (T1); After 12 weeks (T2) | — |
Countries
Germany
Contacts
Public ContactDavid Weise
Asklepios Fachklinkikum
Outcome results
None listed